| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/09/2006 | CN1813820A Chinese medicine glossy ganoderma particle and its preparing process |
| 08/09/2006 | CN1813793A Dermatan sulfate and its derivative oral formulation and preparing method |
| 08/09/2006 | CN1813750A Compound injection formulation of tanshinone IIA sulfonate and ligustrazine hydrochloride and its preparing method |
| 08/09/2006 | CN1813715A Ginkgolide B dropping pill and its preparing method |
| 08/09/2006 | CN1813709A Safflower yellow dropping pill, and its preparing method and use |
| 08/09/2006 | CN1813680A Isepamicin sulfate powder for injection and its preparing method |
| 08/09/2006 | CN1813673A Isepamicin sulfate formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268650C Process for preparing low moledule heparin calcium of low nitrite content |
| 08/09/2006 | CN1268641C 载脂蛋白类似物 Apolipoprotein analogues |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268600C Method for the nitration of phenolic compounds |
| 08/09/2006 | CN1268381C Leukopenia treating Chinese traditional medicine |
| 08/09/2006 | CN1268376C Hematogenesis oral liquid for ladies and preparation technique |
| 08/09/2006 | CN1268341C Tubiflorous desert cistanche preparing containing phenethyl alcohol glycoside and its preparing process and use |
| 08/09/2006 | CN1268332C Kappa opiate agonists for treatment of bladder diseases |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087723 Stable in the absence of albumin or other proteins |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087586 Oligonucleotide compositions and their use to induce differentiation of cells |
| 08/08/2006 | US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087252 For therapy of senile dementia, and inhibition of aggregation of blood platelets |
| 08/08/2006 | US7087224 Method of treating anemia by administering IL-1ra |
| 08/08/2006 | US7087212 Multilayer binding; lamellar surface structure |
| 08/08/2006 | CA2240571C The use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 08/08/2006 | CA2071875C Recombinant human factor viii derivative |
| 08/03/2006 | WO2006081517A2 Embolization using poly-4-hydroxybutyrate particles |
| 08/03/2006 | WO2006081455A1 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 08/03/2006 | WO2006080582A1 Agent for control of function of antigen-presenting cell |
| 08/03/2006 | WO2006080522A1 Food or drug comprising lactic acid bacterium containing mineral |
| 08/03/2006 | WO2006080481A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | WO2006080019A1 Bee-food, honey made by bees fed with it, and uses of such honey |
| 08/03/2006 | WO2006079916A1 Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
| 08/03/2006 | WO2006079610A1 Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
| 08/03/2006 | WO2006079474A1 Prevention and treatment of thromboembolic disorders |
| 08/03/2006 | US20060173047 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172932 Novel erythropoietin receptor agonists |
| 08/03/2006 | US20060172391 BMP-11 compositions |
| 08/03/2006 | US20060172389 Canine erythropoietin gene and recombinant protein |
| 08/03/2006 | CA2596548A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | CA2595882A1 Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
| 08/03/2006 | CA2595376A1 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 08/02/2006 | EP1686181A2 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1685841A1 Prevention and treatment of thromboembolic disorders |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 08/02/2006 | EP1684777A2 Effect of beta-glucan on stem cell recruitment and tissue repair |
| 08/02/2006 | EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 08/02/2006 | EP1684744A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 08/02/2006 | EP1505965B1 Use of the metabolite of valsartan to inhibit platelet aggregation |
| 08/02/2006 | EP1492821B1 Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1345694B1 A method for the manufacture of compositions containing low concentrations of salts |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | CN1812994A Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812792A Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 08/02/2006 | CN1812782A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 08/02/2006 | CN1810836A Human proinsulin-KGD chimeric peptide as new recombinat antithrombotic with thrombocyte GP-IIb-IIIa receptor specificity |
| 08/02/2006 | CN1810832A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 08/02/2006 | CN1810791A Synthesis process of medicine for treating hemopathy |
| 08/02/2006 | CN1810284A Yunnan Rhizoma Paridis extract and its prepn, medicinal use and medicine composition |
| 08/02/2006 | CN1810258A Compound hemostatic originated from venom |
| 08/02/2006 | CN1810241A Pharmaceutical use, medicine composition and prepn process of angelica oil components |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267416C Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267124C Donky-hide blood-supplementing tonic and its preparation method |
| 08/02/2006 | CN1267100C Medicinal composition and its preparation and use |
| 08/02/2006 | CN1267029C Qi- and bood-tonifying nutrient health beverage |
| 08/01/2006 | USRE39219 Isolated Dna |
| 08/01/2006 | US7084254 Ti-4 protein derived from Triatoma infestans exhibiting activity to inhibit platelet aggregation |
| 08/01/2006 | US7084250 asymmetric hydrogenation of 2-[2-acetylamino-3-(4-cyanophenyl)acryloylamino]-2-cyclohexylacetic acid and conversion of the cyano group into the amidine, or a salt thereof, with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt; claimed intermediates |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7084123 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084113 comprises a successfully elucidated crystal structure of a glycoprotein-binding protein originating from snake venom |
| 08/01/2006 | US7084109 FVIIa antagonists |
| 08/01/2006 | US7083970 Comprises ribonuclease barnase marker gene; recombination/genetic engineering; libraries; drug resistance |